A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) in Cairo, Egypt March 4, 2021. Reuters
"Good news" about the Egyptian vaccine will be heard "very soon," Azmy said in remarks to Hadrat Al-Mowaten TV program on Al-Hadath Al-Youm.
An Egyptian coronavirus drug is also undergoing clinical trials and will be made available immediately afterward, Azmy added.
He noted that the Egyptian coronavirus drug, which is considered a "food supplement," can be taken to cure and also prevent coronavirus.
Clinical trials for COVI-VAX officially started in November last year.
When first announced, it was estimated that trials would take six to nine months, according to comments made by Azmy at the time.
COVI-VAX is a product of cooperation between the National Centre for Research (NCR) and the private-sector bio-technology company Vaccine Valley, the Egyptian Drug Authority (EDA) said.
Egypt has locally produced millions of doses of the Chinese Sinovac coronavirus vaccine since mid-2021 in its VACSERA factories in Giza’s 6 of October City and has imported tens of millions of vaccines of all types.
Late in January, the EDA issued an emergency use authorisation for Merck’s COVID-19 drug Molnupiravir and has allowed five national companies to manufacture the oral antiviral as a first stage.
In a separate statement by the health ministry, Head of the EDA Tamer Essam pointed out that local companies “have so far succeeded in producing 25,000 Molnupiravir packages, with the availability of raw materials sufficient to manufacture about 150,000 additional packages".
The first batch of AstraZeneca’s Evusheld — a monoclonal antibody drug that resists the coronavirus — comprising 15,000 doses also arrived in Egypt late in January.